These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs. Patrono C; Patrignani P; García Rodríguez LA J Clin Invest; 2001 Jul; 108(1):7-13. PubMed ID: 11435450 [No Abstract] [Full Text] [Related]
3. The new NSAIDs: cox-2 inhibitors. Capriotti T Medsurg Nurs; 2000 Dec; 9(6):313-7. PubMed ID: 11904867 [No Abstract] [Full Text] [Related]
4. COX-2 inhibitors: cancer prevention or cardiovascular risk? Senior K Lancet Oncol; 2005 Feb; 6(2):68. PubMed ID: 15704289 [No Abstract] [Full Text] [Related]
5. [Clinical pharmacology of selective inhibitors of cyclooxygenase-2]. Patrignani P Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):13-8, 37-40. PubMed ID: 15058604 [No Abstract] [Full Text] [Related]
6. [Thinking about the specific cyclooxygenase-2 inhibitors since its recommendation]. Shi G Zhonghua Nei Ke Za Zhi; 2001 Sep; 40(9):579-80. PubMed ID: 11758234 [No Abstract] [Full Text] [Related]
8. Cyclo-oxygenase 2 inhibitors: an important new drug classification. Kessenich CR Pain Manag Nurs; 2001 Mar; 2(1):13-8. PubMed ID: 11705156 [TBL] [Abstract][Full Text] [Related]
9. Selective cyclo-oxygenase-2 inhibitors and myocardial infarction: how strong is the link? Howes LG; Krum H Drug Saf; 2002; 25(12):829-35. PubMed ID: 12241124 [TBL] [Abstract][Full Text] [Related]
10. The coxibs, selective inhibitors of cyclooxygenase-2. FitzGerald GA; Patrono C N Engl J Med; 2001 Aug; 345(6):433-42. PubMed ID: 11496855 [No Abstract] [Full Text] [Related]
11. [Therapeutic advances with coxibs: few certainties and a lot of doubts]. Jouzeau JY; Daouphars M; Netter P Therapie; 2004; 59(2):207-11. PubMed ID: 15359614 [No Abstract] [Full Text] [Related]
12. [Specific inhibitors of cyclooxygenase-2 (COX-2): current knowledge and perspectives]. Rioda WT; Nervetti A Acta Biomed Ateneo Parmense; 2001; 72(3-4):55-64. PubMed ID: 11889908 [TBL] [Abstract][Full Text] [Related]
13. The new COX-2 inhibitors: rofecoxib (Vioxx) and celecoxib (Celebrex). Wynn RL Gen Dent; 2000; 48(1):16-20. PubMed ID: 11199547 [No Abstract] [Full Text] [Related]
14. Regulation of cyclo-oxygenase-2. Stack E; DuBois RN Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):787-800. PubMed ID: 11566041 [TBL] [Abstract][Full Text] [Related]
15. [Rapid, strong and long-term effectiveness. Coxib also effective in toothache]. MMW Fortschr Med; 2003 Jan; 145(1-2):53. PubMed ID: 12638443 [No Abstract] [Full Text] [Related]
16. [New anti-inflammatory analgetics--are they needed?]. Paakkari I Duodecim; 1999; 115(20):2217-24. PubMed ID: 11973925 [No Abstract] [Full Text] [Related]
17. [Therapy with preferential and specific COX-2 inhibitors]. Stichtenoth DO; Frölich JC Internist (Berl); 2001 Mar; 42(3):421-6. PubMed ID: 11277028 [No Abstract] [Full Text] [Related]
18. Effect of cyclooxygenase-2 inhibitors on blood pressure. Johnson DL; Hisel TM; Phillips BB Ann Pharmacother; 2003 Mar; 37(3):442-6. PubMed ID: 12639178 [TBL] [Abstract][Full Text] [Related]
19. An update on specific COX-2 inhibitors: the COXIBs. Gupta S; Crofford LJ Bull Rheum Dis; 2001; 50(1):1-4. PubMed ID: 12092091 [No Abstract] [Full Text] [Related]